Juliette Zwaveling
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Validation of a Text-Mining Tool for Extracting Routine Clinical Care Data in Early-Stage Resectable Non-Small Cell Lung Cancer.
Journal: JCO clinical cancer informatics
Published: July 29, 2026
Correction: Model‑Based Alternative Dosing Strategies for Subcutaneous Nivolumab to Improve Cost Effectiveness.
Journal: Clinical pharmacokinetics
Published: May 19, 2026
Model-informed approaches to develop drug cost-saving dosing strategies for pembrolizumab.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 10, 2026
Correction: Model‑Based Alternative Dosing Strategies for Subcutaneous Nivolumab to Improve Cost Effectiveness.
Journal: Clinical pharmacokinetics
Published: March 12, 2026
Model-Based Alternative Dosing Strategies for Subcutaneous Nivolumab to Improve Cost Effectiveness.
Journal: Clinical pharmacokinetics
Published: October 01, 2025
Model-Based Alternative Dosing Strategies for Subcutaneous Nivolumab to Improve Cost Effectiveness.
Journal: Clinical pharmacokinetics
Published: October 01, 2025
Severe acute refractory hyperkalaemia associated with liposomal amphotericin B infusion.
Journal: European journal of internal medicine
Published: September 25, 2025
Real World Effectiveness of Durvalumab in Stage III Unresectable Non-small Cell Lung Cancer: What is the Role of PD-L1 Expression?
Journal: Clinical lung cancer
Published: March 03, 2025
The effectiveness of pembrolizumab maintenance with or without pemetrexed after induction treatment for advanced non-squamous Non-Small-Cell Lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: February 28, 2025
Development and Portability of a Text Mining Algorithm for Capturing Disease Progression in Electronic Health Records of Patients With Stage IV Non-Small Cell Lung Cancer.
Journal: JCO clinical cancer informatics
Published: October 04, 2024
Strengthening spontaneous reporting-based signal detection during a pandemic with cases from electronic health records using a natural language processing tool.
Journal: Vaccine
Published: August 29, 2024
Real-world overall survival after alternative dosing for pembrolizumab in the treatment of non-small cell lung cancer: A nationwide retrospective cohort study with a non-inferiority primary objective.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: June 18, 2024
Last Updated: 09/26/2026